Global CD137 Antibody Market Research Report 2026(Status and Outlook)
CD137 Antibody is an antibody directed against the CD137 (also known as 4-1BB) protein in the human immune system.CD137 is a cell surface molecule that belongs to the tumor necrosis factor receptor superfamily and is mainly expressed on activated T cells, natural killer cells and certain antigen-presenting cells. After binding to its ligand, CD137 can promote the proliferation, survival and cytotoxic response of T cells, thereby enhancing the immune response. Combining CD137 antibody with CD137 molecule may have a potential role in immunotherapy, which can be used to enhance anti-tumor immune response and treat diseases such as infection and tumor. Therefore, CD137 antibodies have attracted much attention in immunotherapy research and are regarded as one of the potential therapeutic strategies.
The global CD137 Antibody market size was estimated at USD 493.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CD137 Antibody market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CD137 Antibody market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CD137 Antibody market.
Global CD137 Antibody Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sino Biological, Inc.
Thermo Fisher
LifeSpan BioSciences, Inc
BioLegend
Abcam
Bio-Techne
GeneTex
Bio-Rad Laboratories, Inc.
Arigo Biolaboratories Corp.
Merck
Cell Signaling Technology, Inc.
MyBiosource, Inc.
Boster Biological Technology
Biocare Medical, LLC
Signalway Antibody LLC
NSJ Bioreagents
Leinco Technologies
Wuhan Fine Biotech Co., Ltd.
Elabscience Biotechnology Inc.
Biotium
Bioss Inc
Miltenyi Biotec
Market Segmentation (by Type)
Monoclonal Antibody
Polyclonal Antibody
Market Segmentation (by Application)
Flow Cytometry
ELISA
Immunoprecipitation
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CD137 Antibody Market
Overview of the regional outlook of the CD137 Antibody Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CD137 Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CD137 Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global CD137 Antibody market size was estimated at USD 493.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CD137 Antibody market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CD137 Antibody market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CD137 Antibody market.
Global CD137 Antibody Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sino Biological, Inc.
Thermo Fisher
LifeSpan BioSciences, Inc
BioLegend
Abcam
Bio-Techne
GeneTex
Bio-Rad Laboratories, Inc.
Arigo Biolaboratories Corp.
Merck
Cell Signaling Technology, Inc.
MyBiosource, Inc.
Boster Biological Technology
Biocare Medical, LLC
Signalway Antibody LLC
NSJ Bioreagents
Leinco Technologies
Wuhan Fine Biotech Co., Ltd.
Elabscience Biotechnology Inc.
Biotium
Bioss Inc
Miltenyi Biotec
Market Segmentation (by Type)
Monoclonal Antibody
Polyclonal Antibody
Market Segmentation (by Application)
Flow Cytometry
ELISA
Immunoprecipitation
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CD137 Antibody Market
Overview of the regional outlook of the CD137 Antibody Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CD137 Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CD137 Antibody, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CD137 Antibody
1.2 Key Market Segments
1.2.1 CD137 Antibody Segment by Type
1.2.2 CD137 Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CD137 ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CD137 Antibody Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CD137 Antibody Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CD137 ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CD137 Antibody Product Life Cycle
3.3 Global CD137 Antibody Sales by Manufacturers (2020-2025)
3.4 Global CD137 Antibody Revenue Market Share by Manufacturers (2020-2025)
3.5 CD137 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CD137 Antibody Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CD137 Antibody Market Competitive Situation and Trends
3.8.1 CD137 Antibody Market Concentration Rate
3.8.2 Global 5 and 10 Largest CD137 Antibody Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CD137 ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 CD137 Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CD137 ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CD137 Antibody Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CD137 Antibody Market
5.7 ESG Ratings of Leading Companies
6 CD137 ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CD137 Antibody Sales Market Share by Type (2020-2025)
6.3 Global CD137 Antibody Market Size by Type (2020-2025)
6.4 Global CD137 Antibody Price by Type (2020-2025)
7 CD137 ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CD137 Antibody Market Sales by Application (2020-2025)
7.3 Global CD137 Antibody Market Size (M USD) by Application (2020-2025)
7.4 Global CD137 Antibody Sales Growth Rate by Application (2020-2025)
8 CD137 ANTIBODY MARKET SALES BY REGION
8.1 Global CD137 Antibody Sales by Region
8.1.1 Global CD137 Antibody Sales by Region
8.1.2 Global CD137 Antibody Sales Market Share by Region
8.2 Global CD137 Antibody Market Size by Region
8.2.1 Global CD137 Antibody Market Size by Region
8.2.2 Global CD137 Antibody Market Size by Region
8.3 North America
8.3.1 North America CD137 Antibody Sales by Country
8.3.2 North America CD137 Antibody Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CD137 Antibody Sales by Country
8.4.2 Europe CD137 Antibody Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CD137 Antibody Sales by Region
8.5.2 Asia Pacific CD137 Antibody Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CD137 Antibody Sales by Country
8.6.2 South America CD137 Antibody Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CD137 Antibody Sales by Region
8.7.2 Middle East and Africa CD137 Antibody Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CD137 ANTIBODY MARKET PRODUCTION BY REGION
9.1 Global Production of CD137 Antibody by Region(2020-2025)
9.2 Global CD137 Antibody Revenue Market Share by Region (2020-2025)
9.3 Global CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CD137 Antibody Production
9.4.1 North America CD137 Antibody Production Growth Rate (2020-2025)
9.4.2 North America CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CD137 Antibody Production
9.5.1 Europe CD137 Antibody Production Growth Rate (2020-2025)
9.5.2 Europe CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CD137 Antibody Production (2020-2025)
9.6.1 Japan CD137 Antibody Production Growth Rate (2020-2025)
9.6.2 Japan CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CD137 Antibody Production (2020-2025)
9.7.1 China CD137 Antibody Production Growth Rate (2020-2025)
9.7.2 China CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Basic Information
10.1.2 Sino Biological, Inc. CD137 Antibody Product Overview
10.1.3 Sino Biological, Inc. CD137 Antibody Product Market Performance
10.1.4 Sino Biological, Inc. Business Overview
10.1.5 Sino Biological, Inc. SWOT Analysis
10.1.6 Sino Biological, Inc. Recent Developments
10.2 Thermo Fisher
10.2.1 Thermo Fisher Basic Information
10.2.2 Thermo Fisher CD137 Antibody Product Overview
10.2.3 Thermo Fisher CD137 Antibody Product Market Performance
10.2.4 Thermo Fisher Business Overview
10.2.5 Thermo Fisher SWOT Analysis
10.2.6 Thermo Fisher Recent Developments
10.3 LifeSpan BioSciences, Inc
10.3.1 LifeSpan BioSciences, Inc Basic Information
10.3.2 LifeSpan BioSciences, Inc CD137 Antibody Product Overview
10.3.3 LifeSpan BioSciences, Inc CD137 Antibody Product Market Performance
10.3.4 LifeSpan BioSciences, Inc Business Overview
10.3.5 LifeSpan BioSciences, Inc SWOT Analysis
10.3.6 LifeSpan BioSciences, Inc Recent Developments
10.4 BioLegend
10.4.1 BioLegend Basic Information
10.4.2 BioLegend CD137 Antibody Product Overview
10.4.3 BioLegend CD137 Antibody Product Market Performance
10.4.4 BioLegend Business Overview
10.4.5 BioLegend Recent Developments
10.5 Abcam
10.5.1 Abcam Basic Information
10.5.2 Abcam CD137 Antibody Product Overview
10.5.3 Abcam CD137 Antibody Product Market Performance
10.5.4 Abcam Business Overview
10.5.5 Abcam Recent Developments
10.6 Bio-Techne
10.6.1 Bio-Techne Basic Information
10.6.2 Bio-Techne CD137 Antibody Product Overview
10.6.3 Bio-Techne CD137 Antibody Product Market Performance
10.6.4 Bio-Techne Business Overview
10.6.5 Bio-Techne Recent Developments
10.7 GeneTex
10.7.1 GeneTex Basic Information
10.7.2 GeneTex CD137 Antibody Product Overview
10.7.3 GeneTex CD137 Antibody Product Market Performance
10.7.4 GeneTex Business Overview
10.7.5 GeneTex Recent Developments
10.8 Bio-Rad Laboratories, Inc.
10.8.1 Bio-Rad Laboratories, Inc. Basic Information
10.8.2 Bio-Rad Laboratories, Inc. CD137 Antibody Product Overview
10.8.3 Bio-Rad Laboratories, Inc. CD137 Antibody Product Market Performance
10.8.4 Bio-Rad Laboratories, Inc. Business Overview
10.8.5 Bio-Rad Laboratories, Inc. Recent Developments
10.9 Arigo Biolaboratories Corp.
10.9.1 Arigo Biolaboratories Corp. Basic Information
10.9.2 Arigo Biolaboratories Corp. CD137 Antibody Product Overview
10.9.3 Arigo Biolaboratories Corp. CD137 Antibody Product Market Performance
10.9.4 Arigo Biolaboratories Corp. Business Overview
10.9.5 Arigo Biolaboratories Corp. Recent Developments
10.10 Merck
10.10.1 Merck Basic Information
10.10.2 Merck CD137 Antibody Product Overview
10.10.3 Merck CD137 Antibody Product Market Performance
10.10.4 Merck Business Overview
10.10.5 Merck Recent Developments
10.11 Cell Signaling Technology, Inc.
10.11.1 Cell Signaling Technology, Inc. Basic Information
10.11.2 Cell Signaling Technology, Inc. CD137 Antibody Product Overview
10.11.3 Cell Signaling Technology, Inc. CD137 Antibody Product Market Performance
10.11.4 Cell Signaling Technology, Inc. Business Overview
10.11.5 Cell Signaling Technology, Inc. Recent Developments
10.12 MyBiosource, Inc.
10.12.1 MyBiosource, Inc. Basic Information
10.12.2 MyBiosource, Inc. CD137 Antibody Product Overview
10.12.3 MyBiosource, Inc. CD137 Antibody Product Market Performance
10.12.4 MyBiosource, Inc. Business Overview
10.12.5 MyBiosource, Inc. Recent Developments
10.13 Boster Biological Technology
10.13.1 Boster Biological Technology Basic Information
10.13.2 Boster Biological Technology CD137 Antibody Product Overview
10.13.3 Boster Biological Technology CD137 Antibody Product Market Performance
10.13.4 Boster Biological Technology Business Overview
10.13.5 Boster Biological Technology Recent Developments
10.14 Biocare Medical, LLC
10.14.1 Biocare Medical, LLC Basic Information
10.14.2 Biocare Medical, LLC CD137 Antibody Product Overview
10.14.3 Biocare Medical, LLC CD137 Antibody Product Market Performance
10.14.4 Biocare Medical, LLC Business Overview
10.14.5 Biocare Medical, LLC Recent Developments
10.15 Signalway Antibody LLC
10.15.1 Signalway Antibody LLC Basic Information
10.15.2 Signalway Antibody LLC CD137 Antibody Product Overview
10.15.3 Signalway Antibody LLC CD137 Antibody Product Market Performance
10.15.4 Signalway Antibody LLC Business Overview
10.15.5 Signalway Antibody LLC Recent Developments
10.16 NSJ Bioreagents
10.16.1 NSJ Bioreagents Basic Information
10.16.2 NSJ Bioreagents CD137 Antibody Product Overview
10.16.3 NSJ Bioreagents CD137 Antibody Product Market Performance
10.16.4 NSJ Bioreagents Business Overview
10.16.5 NSJ Bioreagents Recent Developments
10.17 Leinco Technologies
10.17.1 Leinco Technologies Basic Information
10.17.2 Leinco Technologies CD137 Antibody Product Overview
10.17.3 Leinco Technologies CD137 Antibody Product Market Performance
10.17.4 Leinco Technologies Business Overview
10.17.5 Leinco Technologies Recent Developments
10.18 Wuhan Fine Biotech Co., Ltd.
10.18.1 Wuhan Fine Biotech Co., Ltd. Basic Information
10.18.2 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Overview
10.18.3 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Market Performance
10.18.4 Wuhan Fine Biotech Co., Ltd. Business Overview
10.18.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
10.19 Elabscience Biotechnology Inc.
10.19.1 Elabscience Biotechnology Inc. Basic Information
10.19.2 Elabscience Biotechnology Inc. CD137 Antibody Product Overview
10.19.3 Elabscience Biotechnology Inc. CD137 Antibody Product Market Performance
10.19.4 Elabscience Biotechnology Inc. Business Overview
10.19.5 Elabscience Biotechnology Inc. Recent Developments
10.20 Biotium
10.20.1 Biotium Basic Information
10.20.2 Biotium CD137 Antibody Product Overview
10.20.3 Biotium CD137 Antibody Product Market Performance
10.20.4 Biotium Business Overview
10.20.5 Biotium Recent Developments
10.21 Bioss Inc
10.21.1 Bioss Inc Basic Information
10.21.2 Bioss Inc CD137 Antibody Product Overview
10.21.3 Bioss Inc CD137 Antibody Product Market Performance
10.21.4 Bioss Inc Business Overview
10.21.5 Bioss Inc Recent Developments
10.22 Miltenyi Biotec
10.22.1 Miltenyi Biotec Basic Information
10.22.2 Miltenyi Biotec CD137 Antibody Product Overview
10.22.3 Miltenyi Biotec CD137 Antibody Product Market Performance
10.22.4 Miltenyi Biotec Business Overview
10.22.5 Miltenyi Biotec Recent Developments
11 CD137 ANTIBODY MARKET FORECAST BY REGION
11.1 Global CD137 Antibody Market Size Forecast
11.2 Global CD137 Antibody Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CD137 Antibody Market Size Forecast by Country
11.2.3 Asia Pacific CD137 Antibody Market Size Forecast by Region
11.2.4 South America CD137 Antibody Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CD137 Antibody by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CD137 Antibody Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CD137 Antibody by Type (2026-2035)
12.1.2 Global CD137 Antibody Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CD137 Antibody by Type (2026-2035)
12.2 Global CD137 Antibody Market Forecast by Application (2026-2035)
12.2.1 Global CD137 Antibody Sales (K MT) Forecast by Application
12.2.2 Global CD137 Antibody Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CD137 Antibody
1.2 Key Market Segments
1.2.1 CD137 Antibody Segment by Type
1.2.2 CD137 Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CD137 ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CD137 Antibody Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CD137 Antibody Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CD137 ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CD137 Antibody Product Life Cycle
3.3 Global CD137 Antibody Sales by Manufacturers (2020-2025)
3.4 Global CD137 Antibody Revenue Market Share by Manufacturers (2020-2025)
3.5 CD137 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CD137 Antibody Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CD137 Antibody Market Competitive Situation and Trends
3.8.1 CD137 Antibody Market Concentration Rate
3.8.2 Global 5 and 10 Largest CD137 Antibody Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CD137 ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 CD137 Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CD137 ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CD137 Antibody Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CD137 Antibody Market
5.7 ESG Ratings of Leading Companies
6 CD137 ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CD137 Antibody Sales Market Share by Type (2020-2025)
6.3 Global CD137 Antibody Market Size by Type (2020-2025)
6.4 Global CD137 Antibody Price by Type (2020-2025)
7 CD137 ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CD137 Antibody Market Sales by Application (2020-2025)
7.3 Global CD137 Antibody Market Size (M USD) by Application (2020-2025)
7.4 Global CD137 Antibody Sales Growth Rate by Application (2020-2025)
8 CD137 ANTIBODY MARKET SALES BY REGION
8.1 Global CD137 Antibody Sales by Region
8.1.1 Global CD137 Antibody Sales by Region
8.1.2 Global CD137 Antibody Sales Market Share by Region
8.2 Global CD137 Antibody Market Size by Region
8.2.1 Global CD137 Antibody Market Size by Region
8.2.2 Global CD137 Antibody Market Size by Region
8.3 North America
8.3.1 North America CD137 Antibody Sales by Country
8.3.2 North America CD137 Antibody Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CD137 Antibody Sales by Country
8.4.2 Europe CD137 Antibody Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CD137 Antibody Sales by Region
8.5.2 Asia Pacific CD137 Antibody Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CD137 Antibody Sales by Country
8.6.2 South America CD137 Antibody Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CD137 Antibody Sales by Region
8.7.2 Middle East and Africa CD137 Antibody Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CD137 ANTIBODY MARKET PRODUCTION BY REGION
9.1 Global Production of CD137 Antibody by Region(2020-2025)
9.2 Global CD137 Antibody Revenue Market Share by Region (2020-2025)
9.3 Global CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CD137 Antibody Production
9.4.1 North America CD137 Antibody Production Growth Rate (2020-2025)
9.4.2 North America CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CD137 Antibody Production
9.5.1 Europe CD137 Antibody Production Growth Rate (2020-2025)
9.5.2 Europe CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CD137 Antibody Production (2020-2025)
9.6.1 Japan CD137 Antibody Production Growth Rate (2020-2025)
9.6.2 Japan CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CD137 Antibody Production (2020-2025)
9.7.1 China CD137 Antibody Production Growth Rate (2020-2025)
9.7.2 China CD137 Antibody Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Basic Information
10.1.2 Sino Biological, Inc. CD137 Antibody Product Overview
10.1.3 Sino Biological, Inc. CD137 Antibody Product Market Performance
10.1.4 Sino Biological, Inc. Business Overview
10.1.5 Sino Biological, Inc. SWOT Analysis
10.1.6 Sino Biological, Inc. Recent Developments
10.2 Thermo Fisher
10.2.1 Thermo Fisher Basic Information
10.2.2 Thermo Fisher CD137 Antibody Product Overview
10.2.3 Thermo Fisher CD137 Antibody Product Market Performance
10.2.4 Thermo Fisher Business Overview
10.2.5 Thermo Fisher SWOT Analysis
10.2.6 Thermo Fisher Recent Developments
10.3 LifeSpan BioSciences, Inc
10.3.1 LifeSpan BioSciences, Inc Basic Information
10.3.2 LifeSpan BioSciences, Inc CD137 Antibody Product Overview
10.3.3 LifeSpan BioSciences, Inc CD137 Antibody Product Market Performance
10.3.4 LifeSpan BioSciences, Inc Business Overview
10.3.5 LifeSpan BioSciences, Inc SWOT Analysis
10.3.6 LifeSpan BioSciences, Inc Recent Developments
10.4 BioLegend
10.4.1 BioLegend Basic Information
10.4.2 BioLegend CD137 Antibody Product Overview
10.4.3 BioLegend CD137 Antibody Product Market Performance
10.4.4 BioLegend Business Overview
10.4.5 BioLegend Recent Developments
10.5 Abcam
10.5.1 Abcam Basic Information
10.5.2 Abcam CD137 Antibody Product Overview
10.5.3 Abcam CD137 Antibody Product Market Performance
10.5.4 Abcam Business Overview
10.5.5 Abcam Recent Developments
10.6 Bio-Techne
10.6.1 Bio-Techne Basic Information
10.6.2 Bio-Techne CD137 Antibody Product Overview
10.6.3 Bio-Techne CD137 Antibody Product Market Performance
10.6.4 Bio-Techne Business Overview
10.6.5 Bio-Techne Recent Developments
10.7 GeneTex
10.7.1 GeneTex Basic Information
10.7.2 GeneTex CD137 Antibody Product Overview
10.7.3 GeneTex CD137 Antibody Product Market Performance
10.7.4 GeneTex Business Overview
10.7.5 GeneTex Recent Developments
10.8 Bio-Rad Laboratories, Inc.
10.8.1 Bio-Rad Laboratories, Inc. Basic Information
10.8.2 Bio-Rad Laboratories, Inc. CD137 Antibody Product Overview
10.8.3 Bio-Rad Laboratories, Inc. CD137 Antibody Product Market Performance
10.8.4 Bio-Rad Laboratories, Inc. Business Overview
10.8.5 Bio-Rad Laboratories, Inc. Recent Developments
10.9 Arigo Biolaboratories Corp.
10.9.1 Arigo Biolaboratories Corp. Basic Information
10.9.2 Arigo Biolaboratories Corp. CD137 Antibody Product Overview
10.9.3 Arigo Biolaboratories Corp. CD137 Antibody Product Market Performance
10.9.4 Arigo Biolaboratories Corp. Business Overview
10.9.5 Arigo Biolaboratories Corp. Recent Developments
10.10 Merck
10.10.1 Merck Basic Information
10.10.2 Merck CD137 Antibody Product Overview
10.10.3 Merck CD137 Antibody Product Market Performance
10.10.4 Merck Business Overview
10.10.5 Merck Recent Developments
10.11 Cell Signaling Technology, Inc.
10.11.1 Cell Signaling Technology, Inc. Basic Information
10.11.2 Cell Signaling Technology, Inc. CD137 Antibody Product Overview
10.11.3 Cell Signaling Technology, Inc. CD137 Antibody Product Market Performance
10.11.4 Cell Signaling Technology, Inc. Business Overview
10.11.5 Cell Signaling Technology, Inc. Recent Developments
10.12 MyBiosource, Inc.
10.12.1 MyBiosource, Inc. Basic Information
10.12.2 MyBiosource, Inc. CD137 Antibody Product Overview
10.12.3 MyBiosource, Inc. CD137 Antibody Product Market Performance
10.12.4 MyBiosource, Inc. Business Overview
10.12.5 MyBiosource, Inc. Recent Developments
10.13 Boster Biological Technology
10.13.1 Boster Biological Technology Basic Information
10.13.2 Boster Biological Technology CD137 Antibody Product Overview
10.13.3 Boster Biological Technology CD137 Antibody Product Market Performance
10.13.4 Boster Biological Technology Business Overview
10.13.5 Boster Biological Technology Recent Developments
10.14 Biocare Medical, LLC
10.14.1 Biocare Medical, LLC Basic Information
10.14.2 Biocare Medical, LLC CD137 Antibody Product Overview
10.14.3 Biocare Medical, LLC CD137 Antibody Product Market Performance
10.14.4 Biocare Medical, LLC Business Overview
10.14.5 Biocare Medical, LLC Recent Developments
10.15 Signalway Antibody LLC
10.15.1 Signalway Antibody LLC Basic Information
10.15.2 Signalway Antibody LLC CD137 Antibody Product Overview
10.15.3 Signalway Antibody LLC CD137 Antibody Product Market Performance
10.15.4 Signalway Antibody LLC Business Overview
10.15.5 Signalway Antibody LLC Recent Developments
10.16 NSJ Bioreagents
10.16.1 NSJ Bioreagents Basic Information
10.16.2 NSJ Bioreagents CD137 Antibody Product Overview
10.16.3 NSJ Bioreagents CD137 Antibody Product Market Performance
10.16.4 NSJ Bioreagents Business Overview
10.16.5 NSJ Bioreagents Recent Developments
10.17 Leinco Technologies
10.17.1 Leinco Technologies Basic Information
10.17.2 Leinco Technologies CD137 Antibody Product Overview
10.17.3 Leinco Technologies CD137 Antibody Product Market Performance
10.17.4 Leinco Technologies Business Overview
10.17.5 Leinco Technologies Recent Developments
10.18 Wuhan Fine Biotech Co., Ltd.
10.18.1 Wuhan Fine Biotech Co., Ltd. Basic Information
10.18.2 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Overview
10.18.3 Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Market Performance
10.18.4 Wuhan Fine Biotech Co., Ltd. Business Overview
10.18.5 Wuhan Fine Biotech Co., Ltd. Recent Developments
10.19 Elabscience Biotechnology Inc.
10.19.1 Elabscience Biotechnology Inc. Basic Information
10.19.2 Elabscience Biotechnology Inc. CD137 Antibody Product Overview
10.19.3 Elabscience Biotechnology Inc. CD137 Antibody Product Market Performance
10.19.4 Elabscience Biotechnology Inc. Business Overview
10.19.5 Elabscience Biotechnology Inc. Recent Developments
10.20 Biotium
10.20.1 Biotium Basic Information
10.20.2 Biotium CD137 Antibody Product Overview
10.20.3 Biotium CD137 Antibody Product Market Performance
10.20.4 Biotium Business Overview
10.20.5 Biotium Recent Developments
10.21 Bioss Inc
10.21.1 Bioss Inc Basic Information
10.21.2 Bioss Inc CD137 Antibody Product Overview
10.21.3 Bioss Inc CD137 Antibody Product Market Performance
10.21.4 Bioss Inc Business Overview
10.21.5 Bioss Inc Recent Developments
10.22 Miltenyi Biotec
10.22.1 Miltenyi Biotec Basic Information
10.22.2 Miltenyi Biotec CD137 Antibody Product Overview
10.22.3 Miltenyi Biotec CD137 Antibody Product Market Performance
10.22.4 Miltenyi Biotec Business Overview
10.22.5 Miltenyi Biotec Recent Developments
11 CD137 ANTIBODY MARKET FORECAST BY REGION
11.1 Global CD137 Antibody Market Size Forecast
11.2 Global CD137 Antibody Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CD137 Antibody Market Size Forecast by Country
11.2.3 Asia Pacific CD137 Antibody Market Size Forecast by Region
11.2.4 South America CD137 Antibody Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CD137 Antibody by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CD137 Antibody Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CD137 Antibody by Type (2026-2035)
12.1.2 Global CD137 Antibody Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CD137 Antibody by Type (2026-2035)
12.2 Global CD137 Antibody Market Forecast by Application (2026-2035)
12.2.1 Global CD137 Antibody Sales (K MT) Forecast by Application
12.2.2 Global CD137 Antibody Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CD137 Antibody Market Size by Type (M USD)
Table 4. Global CD137 Antibody Market Size by Application
Table 5. CD137 Antibody Market Size Comparison by Region (M USD)
Table 6. Global CD137 Antibody Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CD137 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CD137 Antibody Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CD137 Antibody Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD137 Antibody as of 2025)
Table 11. Global Market CD137 Antibody Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CD137 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CD137 Antibody Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CD137 Antibody Sales by Type (K MT)
Table 27. Global CD137 Antibody Market Size by Type (M USD)
Table 28. Global CD137 Antibody Sales (K MT) by Type (2020-2025)
Table 29. Global CD137 Antibody Sales Market Share by Type (2020-2025)
Table 30. Global CD137 Antibody Market Size (M USD) by Type (2020-2025)
Table 31. Global CD137 Antibody Market Share by Type (2020-2025)
Table 32. Global CD137 Antibody Price (USD/KG) by Type (2020-2025)
Table 33. Global CD137 Antibody Sales (K MT) by Application
Table 34. Global CD137 Antibody Market Size by Application
Table 35. Global CD137 Antibody Sales by Application (2020-2025) & (K MT)
Table 36. Global CD137 Antibody Sales Market Share by Application (2020-2025)
Table 37. Global CD137 Antibody Market Size by Application (2020-2025) & (M USD)
Table 38. Global CD137 Antibody Market Share by Application (2020-2025)
Table 39. Global CD137 Antibody Sales Growth Rate by Application (2020-2025)
Table 40. Global CD137 Antibody Sales by Region (2020-2025) & (K MT)
Table 41. Global CD137 Antibody Sales Market Share by Region (2020-2025)
Table 42. Global CD137 Antibody Market Size by Region (2020-2025) & (M USD)
Table 43. Global CD137 Antibody Market Size by Region (2020-2025)
Table 44. North America CD137 Antibody Sales by Country (2020-2025) & (K MT)
Table 45. North America CD137 Antibody Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CD137 Antibody Sales by Country (2020-2025) & (K MT)
Table 47. Europe CD137 Antibody Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CD137 Antibody Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CD137 Antibody Market Size by Region (2020-2025) & (M USD)
Table 50. South America CD137 Antibody Sales by Country (2020-2025) & (K MT)
Table 51. South America CD137 Antibody Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CD137 Antibody Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CD137 Antibody Market Size by Region (2020-2025) & (M USD)
Table 54. Global CD137 Antibody Production (K MT) by Region(2020-2025)
Table 55. Global CD137 Antibody Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CD137 Antibody Revenue Market Share by Region (2020-2025)
Table 57. Global CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sino Biological, Inc. Basic Information
Table 63. Sino Biological, Inc. CD137 Antibody Product Overview
Table 64. Sino Biological, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sino Biological, Inc. Business Overview
Table 66. Sino Biological, Inc. SWOT Analysis
Table 67. Sino Biological, Inc. Recent Developments
Table 68. Thermo Fisher Basic Information
Table 69. Thermo Fisher CD137 Antibody Product Overview
Table 70. Thermo Fisher CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher SWOT Analysis
Table 73. Thermo Fisher Recent Developments
Table 74. LifeSpan BioSciences, Inc Basic Information
Table 75. LifeSpan BioSciences, Inc CD137 Antibody Product Overview
Table 76. LifeSpan BioSciences, Inc CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. LifeSpan BioSciences, Inc Business Overview
Table 78. LifeSpan BioSciences, Inc SWOT Analysis
Table 79. LifeSpan BioSciences, Inc Recent Developments
Table 80. BioLegend Basic Information
Table 81. BioLegend CD137 Antibody Product Overview
Table 82. BioLegend CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. BioLegend Business Overview
Table 84. BioLegend Recent Developments
Table 85. Abcam Basic Information
Table 86. Abcam CD137 Antibody Product Overview
Table 87. Abcam CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Abcam Business Overview
Table 89. Abcam Recent Developments
Table 90. Bio-Techne Basic Information
Table 91. Bio-Techne CD137 Antibody Product Overview
Table 92. Bio-Techne CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bio-Techne Business Overview
Table 94. Bio-Techne Recent Developments
Table 95. GeneTex Basic Information
Table 96. GeneTex CD137 Antibody Product Overview
Table 97. GeneTex CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GeneTex Business Overview
Table 99. GeneTex Recent Developments
Table 100. Bio-Rad Laboratories, Inc. Basic Information
Table 101. Bio-Rad Laboratories, Inc. CD137 Antibody Product Overview
Table 102. Bio-Rad Laboratories, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories, Inc. Business Overview
Table 104. Bio-Rad Laboratories, Inc. Recent Developments
Table 105. Arigo Biolaboratories Corp. Basic Information
Table 106. Arigo Biolaboratories Corp. CD137 Antibody Product Overview
Table 107. Arigo Biolaboratories Corp. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Arigo Biolaboratories Corp. Business Overview
Table 109. Arigo Biolaboratories Corp. Recent Developments
Table 110. Merck Basic Information
Table 111. Merck CD137 Antibody Product Overview
Table 112. Merck CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Merck Business Overview
Table 114. Merck Recent Developments
Table 115. Cell Signaling Technology, Inc. Basic Information
Table 116. Cell Signaling Technology, Inc. CD137 Antibody Product Overview
Table 117. Cell Signaling Technology, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Cell Signaling Technology, Inc. Business Overview
Table 119. Cell Signaling Technology, Inc. Recent Developments
Table 120. MyBiosource, Inc. Basic Information
Table 121. MyBiosource, Inc. CD137 Antibody Product Overview
Table 122. MyBiosource, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. MyBiosource, Inc. Business Overview
Table 124. MyBiosource, Inc. Recent Developments
Table 125. Boster Biological Technology Basic Information
Table 126. Boster Biological Technology CD137 Antibody Product Overview
Table 127. Boster Biological Technology CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Boster Biological Technology Business Overview
Table 129. Boster Biological Technology Recent Developments
Table 130. Biocare Medical, LLC Basic Information
Table 131. Biocare Medical, LLC CD137 Antibody Product Overview
Table 132. Biocare Medical, LLC CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Biocare Medical, LLC Business Overview
Table 134. Biocare Medical, LLC Recent Developments
Table 135. Signalway Antibody LLC Basic Information
Table 136. Signalway Antibody LLC CD137 Antibody Product Overview
Table 137. Signalway Antibody LLC CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Signalway Antibody LLC Business Overview
Table 139. Signalway Antibody LLC Recent Developments
Table 140. NSJ Bioreagents Basic Information
Table 141. NSJ Bioreagents CD137 Antibody Product Overview
Table 142. NSJ Bioreagents CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. NSJ Bioreagents Business Overview
Table 144. NSJ Bioreagents Recent Developments
Table 145. Leinco Technologies Basic Information
Table 146. Leinco Technologies CD137 Antibody Product Overview
Table 147. Leinco Technologies CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Leinco Technologies Business Overview
Table 149. Leinco Technologies Recent Developments
Table 150. Wuhan Fine Biotech Co., Ltd. Basic Information
Table 151. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Overview
Table 152. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Wuhan Fine Biotech Co., Ltd. Business Overview
Table 154. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 155. Elabscience Biotechnology Inc. Basic Information
Table 156. Elabscience Biotechnology Inc. CD137 Antibody Product Overview
Table 157. Elabscience Biotechnology Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Elabscience Biotechnology Inc. Business Overview
Table 159. Elabscience Biotechnology Inc. Recent Developments
Table 160. Biotium Basic Information
Table 161. Biotium CD137 Antibody Product Overview
Table 162. Biotium CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Biotium Business Overview
Table 164. Biotium Recent Developments
Table 165. Bioss Inc Basic Information
Table 166. Bioss Inc CD137 Antibody Product Overview
Table 167. Bioss Inc CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Bioss Inc Business Overview
Table 169. Bioss Inc Recent Developments
Table 170. Miltenyi Biotec Basic Information
Table 171. Miltenyi Biotec CD137 Antibody Product Overview
Table 172. Miltenyi Biotec CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Miltenyi Biotec Business Overview
Table 174. Miltenyi Biotec Recent Developments
Table 175. Global CD137 Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 176. Global CD137 Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 177. North America CD137 Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 178. North America CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 179. Europe CD137 Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 180. Europe CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 181. Asia Pacific CD137 Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 182. Asia Pacific CD137 Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 183. South America CD137 Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 184. South America CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 185. Middle East and Africa CD137 Antibody Sales Forecast by Country (2026-2035) & (Units)
Table 186. Middle East and Africa CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 187. Global CD137 Antibody Sales Forecast by Type (2026-2035) & (K MT)
Table 188. Global CD137 Antibody Market Size Forecast by Type (2026-2035) & (M USD)
Table 189. Global CD137 Antibody Price Forecast by Type (2026-2035) & (USD/KG)
Table 190. Global CD137 Antibody Sales (K MT) Forecast by Application (2026-2035)
Table 191. Global CD137 Antibody Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CD137 Antibody Market Size by Type (M USD)
Table 4. Global CD137 Antibody Market Size by Application
Table 5. CD137 Antibody Market Size Comparison by Region (M USD)
Table 6. Global CD137 Antibody Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CD137 Antibody Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CD137 Antibody Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CD137 Antibody Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD137 Antibody as of 2025)
Table 11. Global Market CD137 Antibody Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CD137 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CD137 Antibody Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CD137 Antibody Sales by Type (K MT)
Table 27. Global CD137 Antibody Market Size by Type (M USD)
Table 28. Global CD137 Antibody Sales (K MT) by Type (2020-2025)
Table 29. Global CD137 Antibody Sales Market Share by Type (2020-2025)
Table 30. Global CD137 Antibody Market Size (M USD) by Type (2020-2025)
Table 31. Global CD137 Antibody Market Share by Type (2020-2025)
Table 32. Global CD137 Antibody Price (USD/KG) by Type (2020-2025)
Table 33. Global CD137 Antibody Sales (K MT) by Application
Table 34. Global CD137 Antibody Market Size by Application
Table 35. Global CD137 Antibody Sales by Application (2020-2025) & (K MT)
Table 36. Global CD137 Antibody Sales Market Share by Application (2020-2025)
Table 37. Global CD137 Antibody Market Size by Application (2020-2025) & (M USD)
Table 38. Global CD137 Antibody Market Share by Application (2020-2025)
Table 39. Global CD137 Antibody Sales Growth Rate by Application (2020-2025)
Table 40. Global CD137 Antibody Sales by Region (2020-2025) & (K MT)
Table 41. Global CD137 Antibody Sales Market Share by Region (2020-2025)
Table 42. Global CD137 Antibody Market Size by Region (2020-2025) & (M USD)
Table 43. Global CD137 Antibody Market Size by Region (2020-2025)
Table 44. North America CD137 Antibody Sales by Country (2020-2025) & (K MT)
Table 45. North America CD137 Antibody Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CD137 Antibody Sales by Country (2020-2025) & (K MT)
Table 47. Europe CD137 Antibody Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CD137 Antibody Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CD137 Antibody Market Size by Region (2020-2025) & (M USD)
Table 50. South America CD137 Antibody Sales by Country (2020-2025) & (K MT)
Table 51. South America CD137 Antibody Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CD137 Antibody Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CD137 Antibody Market Size by Region (2020-2025) & (M USD)
Table 54. Global CD137 Antibody Production (K MT) by Region(2020-2025)
Table 55. Global CD137 Antibody Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CD137 Antibody Revenue Market Share by Region (2020-2025)
Table 57. Global CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CD137 Antibody Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sino Biological, Inc. Basic Information
Table 63. Sino Biological, Inc. CD137 Antibody Product Overview
Table 64. Sino Biological, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sino Biological, Inc. Business Overview
Table 66. Sino Biological, Inc. SWOT Analysis
Table 67. Sino Biological, Inc. Recent Developments
Table 68. Thermo Fisher Basic Information
Table 69. Thermo Fisher CD137 Antibody Product Overview
Table 70. Thermo Fisher CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Thermo Fisher Business Overview
Table 72. Thermo Fisher SWOT Analysis
Table 73. Thermo Fisher Recent Developments
Table 74. LifeSpan BioSciences, Inc Basic Information
Table 75. LifeSpan BioSciences, Inc CD137 Antibody Product Overview
Table 76. LifeSpan BioSciences, Inc CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. LifeSpan BioSciences, Inc Business Overview
Table 78. LifeSpan BioSciences, Inc SWOT Analysis
Table 79. LifeSpan BioSciences, Inc Recent Developments
Table 80. BioLegend Basic Information
Table 81. BioLegend CD137 Antibody Product Overview
Table 82. BioLegend CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. BioLegend Business Overview
Table 84. BioLegend Recent Developments
Table 85. Abcam Basic Information
Table 86. Abcam CD137 Antibody Product Overview
Table 87. Abcam CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Abcam Business Overview
Table 89. Abcam Recent Developments
Table 90. Bio-Techne Basic Information
Table 91. Bio-Techne CD137 Antibody Product Overview
Table 92. Bio-Techne CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bio-Techne Business Overview
Table 94. Bio-Techne Recent Developments
Table 95. GeneTex Basic Information
Table 96. GeneTex CD137 Antibody Product Overview
Table 97. GeneTex CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GeneTex Business Overview
Table 99. GeneTex Recent Developments
Table 100. Bio-Rad Laboratories, Inc. Basic Information
Table 101. Bio-Rad Laboratories, Inc. CD137 Antibody Product Overview
Table 102. Bio-Rad Laboratories, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories, Inc. Business Overview
Table 104. Bio-Rad Laboratories, Inc. Recent Developments
Table 105. Arigo Biolaboratories Corp. Basic Information
Table 106. Arigo Biolaboratories Corp. CD137 Antibody Product Overview
Table 107. Arigo Biolaboratories Corp. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Arigo Biolaboratories Corp. Business Overview
Table 109. Arigo Biolaboratories Corp. Recent Developments
Table 110. Merck Basic Information
Table 111. Merck CD137 Antibody Product Overview
Table 112. Merck CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Merck Business Overview
Table 114. Merck Recent Developments
Table 115. Cell Signaling Technology, Inc. Basic Information
Table 116. Cell Signaling Technology, Inc. CD137 Antibody Product Overview
Table 117. Cell Signaling Technology, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Cell Signaling Technology, Inc. Business Overview
Table 119. Cell Signaling Technology, Inc. Recent Developments
Table 120. MyBiosource, Inc. Basic Information
Table 121. MyBiosource, Inc. CD137 Antibody Product Overview
Table 122. MyBiosource, Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. MyBiosource, Inc. Business Overview
Table 124. MyBiosource, Inc. Recent Developments
Table 125. Boster Biological Technology Basic Information
Table 126. Boster Biological Technology CD137 Antibody Product Overview
Table 127. Boster Biological Technology CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Boster Biological Technology Business Overview
Table 129. Boster Biological Technology Recent Developments
Table 130. Biocare Medical, LLC Basic Information
Table 131. Biocare Medical, LLC CD137 Antibody Product Overview
Table 132. Biocare Medical, LLC CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Biocare Medical, LLC Business Overview
Table 134. Biocare Medical, LLC Recent Developments
Table 135. Signalway Antibody LLC Basic Information
Table 136. Signalway Antibody LLC CD137 Antibody Product Overview
Table 137. Signalway Antibody LLC CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Signalway Antibody LLC Business Overview
Table 139. Signalway Antibody LLC Recent Developments
Table 140. NSJ Bioreagents Basic Information
Table 141. NSJ Bioreagents CD137 Antibody Product Overview
Table 142. NSJ Bioreagents CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. NSJ Bioreagents Business Overview
Table 144. NSJ Bioreagents Recent Developments
Table 145. Leinco Technologies Basic Information
Table 146. Leinco Technologies CD137 Antibody Product Overview
Table 147. Leinco Technologies CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Leinco Technologies Business Overview
Table 149. Leinco Technologies Recent Developments
Table 150. Wuhan Fine Biotech Co., Ltd. Basic Information
Table 151. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Product Overview
Table 152. Wuhan Fine Biotech Co., Ltd. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Wuhan Fine Biotech Co., Ltd. Business Overview
Table 154. Wuhan Fine Biotech Co., Ltd. Recent Developments
Table 155. Elabscience Biotechnology Inc. Basic Information
Table 156. Elabscience Biotechnology Inc. CD137 Antibody Product Overview
Table 157. Elabscience Biotechnology Inc. CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Elabscience Biotechnology Inc. Business Overview
Table 159. Elabscience Biotechnology Inc. Recent Developments
Table 160. Biotium Basic Information
Table 161. Biotium CD137 Antibody Product Overview
Table 162. Biotium CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Biotium Business Overview
Table 164. Biotium Recent Developments
Table 165. Bioss Inc Basic Information
Table 166. Bioss Inc CD137 Antibody Product Overview
Table 167. Bioss Inc CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Bioss Inc Business Overview
Table 169. Bioss Inc Recent Developments
Table 170. Miltenyi Biotec Basic Information
Table 171. Miltenyi Biotec CD137 Antibody Product Overview
Table 172. Miltenyi Biotec CD137 Antibody Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Miltenyi Biotec Business Overview
Table 174. Miltenyi Biotec Recent Developments
Table 175. Global CD137 Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 176. Global CD137 Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 177. North America CD137 Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 178. North America CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 179. Europe CD137 Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 180. Europe CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 181. Asia Pacific CD137 Antibody Sales Forecast by Region (2026-2035) & (K MT)
Table 182. Asia Pacific CD137 Antibody Market Size Forecast by Region (2026-2035) & (M USD)
Table 183. South America CD137 Antibody Sales Forecast by Country (2026-2035) & (K MT)
Table 184. South America CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 185. Middle East and Africa CD137 Antibody Sales Forecast by Country (2026-2035) & (Units)
Table 186. Middle East and Africa CD137 Antibody Market Size Forecast by Country (2026-2035) & (M USD)
Table 187. Global CD137 Antibody Sales Forecast by Type (2026-2035) & (K MT)
Table 188. Global CD137 Antibody Market Size Forecast by Type (2026-2035) & (M USD)
Table 189. Global CD137 Antibody Price Forecast by Type (2026-2035) & (USD/KG)
Table 190. Global CD137 Antibody Sales (K MT) Forecast by Application (2026-2035)
Table 191. Global CD137 Antibody Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CD137 Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CD137 Antibody Market Size (M USD), 2025-2035
Figure 5. Global CD137 Antibody Market Size (M USD) (2020-2035)
Figure 6. Global CD137 Antibody Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CD137 Antibody Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CD137 Antibody Product Life Cycle
Figure 13. CD137 Antibody Sales Share by Manufacturers in 2025
Figure 14. Global CD137 Antibody Revenue Share by Manufacturers in 2025
Figure 15. CD137 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CD137 Antibody Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CD137 Antibody Revenue in 2025
Figure 18. Industry Chain Map of CD137 Antibody
Figure 19. Global CD137 Antibody Market PEST Analysis
Figure 20. Global CD137 Antibody Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CD137 Antibody Market Share by Type
Figure 27. Sales Market Share of CD137 Antibody by Type (2020-2025)
Figure 28. Sales Market Share of CD137 Antibody by Type in 2025
Figure 29. Market Share of CD137 Antibody by Type (2020-2025)
Figure 30. Market Share of CD137 Antibody by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CD137 Antibody Market Share by Application
Figure 33. Global CD137 Antibody Sales Market Share by Application (2020-2025)
Figure 34. Global CD137 Antibody Sales Market Share by Application in 2025
Figure 35. Global CD137 Antibody Market Share by Application (2020-2025)
Figure 36. Global CD137 Antibody Market Share by Application in 2025
Figure 37. Global CD137 Antibody Sales Growth Rate by Application (2020-2025)
Figure 38. Global CD137 Antibody Sales Market Share by Region (2020-2025)
Figure 39. Global CD137 Antibody Market Size by Region (2020-2025)
Figure 40. North America CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CD137 Antibody Sales Market Share by Country in 2024
Figure 43. North America CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CD137 Antibody Market Size by Country in 2024
Figure 45. U.S. CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CD137 Antibody Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CD137 Antibody Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CD137 Antibody Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CD137 Antibody Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CD137 Antibody Sales Market Share by Country in 2024
Figure 53. Europe CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CD137 Antibody Market Size by Country in 2024
Figure 55. Germany CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CD137 Antibody Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CD137 Antibody Sales Market Share by Region in 2024
Figure 67. Asia Pacific CD137 Antibody Market Size by Region in 2024
Figure 68. China CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CD137 Antibody Sales and Growth Rate (K MT)
Figure 79. South America CD137 Antibody Sales Market Share by Country in 2024
Figure 80. South America CD137 Antibody Market Size and Growth Rate (M USD)
Figure 81. South America CD137 Antibody Market Size by Country in 2024
Figure 82. Brazil CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CD137 Antibody Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CD137 Antibody Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CD137 Antibody Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CD137 Antibody Market Size by Region in 2024
Figure 92. Saudi Arabia CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CD137 Antibody Production Market Share by Region (2020-2025)
Figure 103. North America CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 106. China CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CD137 Antibody Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CD137 Antibody Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CD137 Antibody Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CD137 Antibody Market Share Forecast by Type (2026-2035)
Figure 111. Global CD137 Antibody Sales Forecast by Application (2026-2035)
Figure 112. Global CD137 Antibody Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of CD137 Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CD137 Antibody Market Size (M USD), 2025-2035
Figure 5. Global CD137 Antibody Market Size (M USD) (2020-2035)
Figure 6. Global CD137 Antibody Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CD137 Antibody Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CD137 Antibody Product Life Cycle
Figure 13. CD137 Antibody Sales Share by Manufacturers in 2025
Figure 14. Global CD137 Antibody Revenue Share by Manufacturers in 2025
Figure 15. CD137 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CD137 Antibody Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CD137 Antibody Revenue in 2025
Figure 18. Industry Chain Map of CD137 Antibody
Figure 19. Global CD137 Antibody Market PEST Analysis
Figure 20. Global CD137 Antibody Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CD137 Antibody Market Share by Type
Figure 27. Sales Market Share of CD137 Antibody by Type (2020-2025)
Figure 28. Sales Market Share of CD137 Antibody by Type in 2025
Figure 29. Market Share of CD137 Antibody by Type (2020-2025)
Figure 30. Market Share of CD137 Antibody by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CD137 Antibody Market Share by Application
Figure 33. Global CD137 Antibody Sales Market Share by Application (2020-2025)
Figure 34. Global CD137 Antibody Sales Market Share by Application in 2025
Figure 35. Global CD137 Antibody Market Share by Application (2020-2025)
Figure 36. Global CD137 Antibody Market Share by Application in 2025
Figure 37. Global CD137 Antibody Sales Growth Rate by Application (2020-2025)
Figure 38. Global CD137 Antibody Sales Market Share by Region (2020-2025)
Figure 39. Global CD137 Antibody Market Size by Region (2020-2025)
Figure 40. North America CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CD137 Antibody Sales Market Share by Country in 2024
Figure 43. North America CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CD137 Antibody Market Size by Country in 2024
Figure 45. U.S. CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CD137 Antibody Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CD137 Antibody Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CD137 Antibody Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CD137 Antibody Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CD137 Antibody Sales Market Share by Country in 2024
Figure 53. Europe CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CD137 Antibody Market Size by Country in 2024
Figure 55. Germany CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CD137 Antibody Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CD137 Antibody Sales Market Share by Region in 2024
Figure 67. Asia Pacific CD137 Antibody Market Size by Region in 2024
Figure 68. China CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CD137 Antibody Sales and Growth Rate (K MT)
Figure 79. South America CD137 Antibody Sales Market Share by Country in 2024
Figure 80. South America CD137 Antibody Market Size and Growth Rate (M USD)
Figure 81. South America CD137 Antibody Market Size by Country in 2024
Figure 82. Brazil CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CD137 Antibody Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CD137 Antibody Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CD137 Antibody Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CD137 Antibody Market Size by Region in 2024
Figure 92. Saudi Arabia CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CD137 Antibody Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CD137 Antibody Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CD137 Antibody Production Market Share by Region (2020-2025)
Figure 103. North America CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 106. China CD137 Antibody Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CD137 Antibody Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CD137 Antibody Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CD137 Antibody Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CD137 Antibody Market Share Forecast by Type (2026-2035)
Figure 111. Global CD137 Antibody Sales Forecast by Application (2026-2035)
Figure 112. Global CD137 Antibody Market Share Forecast by Application (2026-2035)
